neelakantan et al. 2018 biochemical pharmacology 5-amino-1mq Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Is Adamax FDA Approved Size:2g - $57.03 research-metabolic
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20